Ifosfamide: A Milestone Drug, International Meeting, Padua, February 17-18, 2003CARTEI, Giuseppe.Oncology. 2003, Vol 65, issn 0030-2414, 110 p., SUP2Conference Proceedings

B-cell lymphoproliferation in primary Sjögren's syndromeTZIOUFAS, A. G.Clinical and experimental rheumatology (Testo stampato). 1996, Vol 14, pp S65-S70, issn 0392-856X, SUP14Conference Paper

Side effects of ifosfamideKLASTERSKY, J.Oncology. 2003, Vol 65, pp 7-10, issn 0030-2414, 4 p., SUP2Conference Paper

Ifosfamide in germ cell tumorsEINHORN, L. H.Oncology. 2003, Vol 65, pp 73-75, issn 0030-2414, 3 p., SUP2Conference Paper

Monitoring clonal expansion in the laboratorySALA, P; TONUTTI, E.Clinical and experimental rheumatology (Testo stampato). 1996, Vol 14, pp S31-S35, issn 0392-856X, SUP14Conference Paper

Sjögren's syndrome, mixed cryoglobulinaemia and the monoclonal gammopathiesVITALI, C; BOMBARDIERI, S.Clinical and experimental rheumatology (Testo stampato). 1996, Vol 14, pp S59-S63, issn 0392-856X, SUP14Conference Paper

Ifosfamide in urologic cancerBOCCARDO, F; GUGLIELMINI, P.Oncology. 2003, Vol 65, pp 67-72, issn 0030-2414, 6 p., SUP2Conference Paper

Neurological toxicity of ifosfamideNICOLAO, P; GIOMETTO, B.Oncology. 2003, Vol 65, pp 11-16, issn 0030-2414, 6 p., SUP2Conference Paper

Ifosfamide and cyclophosphamide: Effects on immunosurveillanceBINOTTO, G; TRENTIN, L; SEMENZATO, G et al.Oncology. 2003, Vol 65, pp 17-20, issn 0030-2414, 4 p., SUP2Conference Paper

Ifosfamide in non-small cell lung cancerBONI, C; ZANELLI, F.Oncology. 2003, Vol 65, pp 50-54, issn 0030-2414, 5 p., SUP2Conference Paper

Ifosfamide in hematological malignancies of adultsRODEGHIERO, F; ELICE, F.Oncology. 2003, Vol 65, pp 85-93, issn 0030-2414, 9 p., SUP2Conference Paper

Ifosfamide in thymic neoplasmsDANIELE, O; FORNASIERO, A.Oncology. 2003, Vol 65, pp 44-45, issn 0030-2414, 2 p., SUP2Conference Paper

Ifosfamide in small cell lung cancerMARANGOLO, M; GIOVANIS, P.Oncology. 2003, Vol 65, pp 46-49, issn 0030-2414, 4 p., SUP2Conference Paper

Autoimmune diseases and monoclonal gammopathiesYOUINOU, P; LE CORRE, R; DUEYMES, M et al.Clinical and experimental rheumatology (Testo stampato). 1996, Vol 14, pp S55-S58, issn 0392-856X, SUP14Conference Paper

Helicobacter pylori, gastric MALT and B-cell clonalitySORRENTINO, D; FERRACCIOLI, G. F; LABOMBARDA, A et al.Clinical and experimental rheumatology (Testo stampato). 1996, Vol 14, pp S51-S54, issn 0392-856X, SUP14Conference Paper

Hepatitis C virus infection and clonal B-cell expansionSANSONNO, D; CORNACCHIULO, V; IACOBELLI, A. R et al.Clinical and experimental rheumatology (Testo stampato). 1996, Vol 14, pp S45-S50, issn 0392-856X, SUP14Conference Paper

Ifosfamide in advanced/disseminated breast cancerSORIO, R; LOMBARDI, D; SPAZZAPAN, S et al.Oncology. 2003, Vol 65, pp 55-58, issn 0030-2414, 4 p., SUP2Conference Paper

Antiblastic drug combinations with ifosfamide: An updateFULFARO, F; VALERIO, M. R; BADALAMENTI, G et al.Oncology. 2003, Vol 65, pp 21-30, issn 0030-2414, 10 p., SUP2Conference Paper

Ifosfamide with regional hyperthermia in soft-tissue sarcomasSCHLEMMER, M; WENDTNER, C. M; ISSELS, R. D et al.Oncology. 2003, Vol 65, pp 76-79, issn 0030-2414, 4 p., SUP2Conference Paper

Role of ifosfamide in cervical cancer: An overviewBUDA, A; DELL'ANNA, T; SIGNORELLI, M et al.Oncology. 2003, Vol 65, pp 63-66, issn 0030-2414, 4 p., SUP2Conference Paper

Ifosfamide in pediatric solid tumorsCARLI, M; PASSONE, E; PERILONGO, G et al.Oncology. 2003, Vol 65, pp 99-104, issn 0030-2414, 6 p., SUP2Conference Paper

Dose finding of ifosfamide administered with a chronic two-week continuous infusionCARTEI, G; CLOCCHIATTI, L; SACCO, C et al.Oncology. 2003, Vol 65, pp 31-36, issn 0030-2414, 6 p., SUP2Conference Paper